These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32012132)

  • 1. Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study.
    Silva CMD; Peder LD; Silva ES; Previdelli I; Pereira OCN; Teixeira JJV; Bertolini DA
    J Infect Dev Ctries; 2018 Nov; 12(11):1009-1018. PubMed ID: 32012132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
    Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
    PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.
    Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T
    J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential T-cell profiles determined by Hepatitis B surface antigen decrease among people with Human Immunodeficiency Virus /Hepatitis B Virus coinfection on treatment.
    Li X; Xu L; Lu L; Liu X; Yang Y; Wu Y; Zhu T; Li X; Li Y; Song X; Han Y; Lyu W; Cao W; Li T
    J Transl Med; 2024 Oct; 22(1):901. PubMed ID: 39367456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria.
    Nnakenyi ID; Uchechukwu C; Nto-Ezimah U
    Afr Health Sci; 2020 Jun; 20(2):579-586. PubMed ID: 33163019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
    Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
    Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
    Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers.
    Malagnino V; Cerva C; Teti E; Campogiani L; Compagno M; Foroghi Biland L; Saderi L; Armenia D; Salpini R; Svicher V; Sotgiu G; Iannetta M; Andreoni M; Sarmati L
    Sci Rep; 2021 Feb; 11(1):3965. PubMed ID: 33597631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Liver Diseases after Initiation of Antiretroviral Therapy in HIV-Infected Patients with and without HBV or HCV Coinfection.
    Phusanti S; Manosudprasit K; Sungkanuparph S
    J Int Assoc Provid AIDS Care; 2017; 16(2):194-200. PubMed ID: 28071205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
    PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of liver disease in HIV-infected children and adolescents.
    Pokorska-Śpiewak M; Stańska-Perka A; Popielska J; Ołdakowska A; Coupland U; Zawadka K; Szczepańska-Putz M; Marczyńska M
    Sci Rep; 2017 Sep; 7(1):12309. PubMed ID: 28951598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
    Majekodunmi AO; Thorne C; Malyuta R; Volokha A; Callard RE; Klein NJ; Lewis J;
    Pediatr Infect Dis J; 2017 May; 36(5):e123-e129. PubMed ID: 28403051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.